Approve this article for publication
Cells. 2021 Jun 7;10(6):1417. doi: 10.3390/cells10061417.
ABSTRACT
Lung transplantation (LTx) is the gold standard treatment for end-stage lung disease; however, waitlist mortality remains high due to a shortage of suitable donor lungs. Organ quality can be compromised by lung
Approve this article for publication
Injury. 2020 Dec;51 Suppl 4:S121-S125. doi: 10.1016/j.injury.2020.05.029. Epub 2020 May 23.
ABSTRACT
BACKGROUND: The keystone perforator flap is a simple, popular form of advancement flap that can solve many defects of the lower extremity that can avoid consideration of
Approve this article for publication
Future Cardiol. 2021 Jan;17(1):11-17. doi: 10.2217/fca-2020-0070. Epub 2020 Jul 6.
ABSTRACT
Orthotopic heart transplantation is the gold standard treatment for end-stage heart failure. However, the persistent shortage of available donor organs has resulted in an ever-increasing waitlist and longer
Approve this article for publication
Nat Commun. 2020 Jun 12;11(1):2976. doi: 10.1038/s41467-020-16782-9.
ABSTRACT
Pre-clinical heart transplantation studies have shown that ex vivo non-ischemic heart preservation (NIHP) can be safely used for 24 h. Here we perform a prospective, open-label, non-randomized phase II study comparing
Approve this article for publication
Ann Thorac Surg. 2020 Dec;110(6):1861-1868. doi: 10.1016/j.athoracsur.2020.05.079. Epub 2020 Jul 9.
ABSTRACT
BACKGROUND: Ischemia-reperfusion associated with prolonged warm ischemia during donation after circulatory death (DCD) induces acute lung injury. The objective of this study was to combine ex vivo
Approve this article for publication
Transplant Proc. 2020 Dec;52(10):2941-2946. doi: 10.1016/j.transproceed.2020.05.007. Epub 2020 Jul 2.
ABSTRACT
BACKGROUND: Normothermic ex vivo lung perfusion (EVLP) has been used successfully to evaluate and recondition marginal donor lungs; however, multiple barriers continue to prevent its widespread adoption. We
Approve this article for publication
J Heart Lung Transplant. 2020 Jun 29:S1053-2498(20)31625-9. doi: 10.1016/j.healun.2020.06.023. Online ahead of print.
ABSTRACT
BACKGROUND: Donation after circulatory death (DCD) offers an additional source of cardiac allografts, potentially allowing expansion of the donor pool, but is limited owing to
Approve this article for publication
Ann Palliat Med. 2020 Jul;9(4):1476-1487. doi: 10.21037/apm-20-131. Epub 2020 Jul 13.
ABSTRACT
BACKGROUND: Both machine perfusion (MP) of donor hearts with autologous blood and crystalloid perfusates have advantages and disadvantages. Currently, which of the aforementioned preservation strategies can better
Approve this article for publication
Methods Mol Biol. 2020;2204:217-224. doi: 10.1007/978-1-0716-0904-0_19.
ABSTRACT
In recent years, medical advances make lung transplantation become a standard treatment for terminal lung diseases (such as emphysema, pulmonary fibrosis, pulmonary cystic fibrosis, and pulmonary arterial hypertension) that cannot be cured
Approve this article for publication
Transplantation. 2020 Aug;104(8):1542-1552. doi: 10.1097/TP.0000000000003139.
ABSTRACT
Uncontrolled donation after circulatory death (uDCD) refers to donation from persons who die following an unexpected and unsuccessfully resuscitated cardiac arrest. Despite the large potential for uDCD, programs of this kind only exist
